The effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion - A preliminary prospective study
I. Florentino-pineda et al., The effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion - A preliminary prospective study, SPINE, 26(10), 2001, pp. 1147-1151
Study Design. A prospective study evaluating the efficacy of epsilon -amino
caproic acid (EACA) in decreasing perioperative blood loss in idiopathic sc
oliosis.
Objectives. To compare the perioperative blood loss and need for blood repl
acement in two groups of patients undergoing surgery for idiopathic scolios
is. One group received intraoperative EACA; the other did not and served as
controls.
Summary of Background Data. Excessive blood loss increases the operative ti
me, risk for blood product disease transmission, postoperative complication
s, and costs associated with posterior spinal fusion and instrumentation. E
ACA is an antifibrinolytic agent that has been shown to be effective in red
ucing perioperative blood loss during pediatric cardiothoracic surgical pro
cedures. We hypothesized that it would also be effective in lowering blood
loss during posterior spinal fusion for idiopathic scoliosis.
Methods. We compared the perioperative blood loss of 28 consecutive pediatr
ic patients with idiopathic scoliosis who underwent posterior spinal fusion
and received intraoperative EACA with 31 consecutive patients who did not
receive this medication and served as a control group.
Results. The patients in both groups were similar. Patients in the EACA gro
up demonstrated statistically significant decreases in total estimated peri
operative blood loss and the need for autologous blood transfusion. The pat
ients in the EACA group had no intraoperative or postoperative complication
s related to the use of this medication.
Conclusions. Based on these preliminary findings, we believe that EACA is h
elpful in decreasing blood loss in patients undergoing posterior spinal fus
ion and instrumentation, and may decrease the number of autologous units ne
eded to maintain safe perioperative hemoglobin levels, thereby improving sa
fety and lowering cost associated with scoliosis surgery.